Name | Number of supported studies | Average coverage | |
---|---|---|---|
precursor B cell | 6 studies | 56% ± 25% | |
pro-B cell | 5 studies | 85% ± 5% | |
B cell | 4 studies | 34% ± 14% | |
hematopoietic precursor cell | 3 studies | 51% ± 24% | |
common myeloid progenitor | 3 studies | 33% ± 7% | |
hematopoietic stem cell | 3 studies | 29% ± 10% |
Insufficient scRNA-seq data for expression of IGLL1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 73% | 5.36 | 422 / 578 | 27% | 1.10 | 307 / 1155 |
spleen | 99% | 26.18 | 238 / 241 | 0% | 0 | 0 / 0 |
kidney | 80% | 6.40 | 71 / 89 | 5% | 0.19 | 41 / 901 |
stomach | 55% | 3.52 | 199 / 359 | 26% | 4.75 | 75 / 286 |
peripheral blood | 81% | 28.19 | 753 / 929 | 0% | 0 | 0 / 0 |
ovary | 69% | 3.37 | 124 / 180 | 8% | 0.41 | 36 / 430 |
intestine | 62% | 5.74 | 597 / 966 | 12% | 0.53 | 63 / 527 |
thymus | 54% | 3.52 | 355 / 653 | 18% | 9.36 | 110 / 605 |
brain | 67% | 3.76 | 1757 / 2642 | 0% | 0.00 | 2 / 705 |
bladder | 57% | 1.90 | 12 / 21 | 5% | 0.14 | 27 / 504 |
prostate | 61% | 3.23 | 150 / 245 | 0% | 0.01 | 2 / 502 |
breast | 51% | 3.06 | 234 / 459 | 5% | 0.30 | 60 / 1118 |
uterus | 42% | 1.68 | 71 / 170 | 3% | 0.12 | 16 / 459 |
esophagus | 28% | 1.05 | 400 / 1445 | 16% | 1.12 | 29 / 183 |
liver | 33% | 1.20 | 75 / 226 | 2% | 0.04 | 10 / 406 |
skin | 25% | 0.87 | 453 / 1809 | 10% | 0.31 | 49 / 472 |
adrenal gland | 34% | 1.32 | 87 / 258 | 1% | 0.03 | 2 / 230 |
adipose | 33% | 1.20 | 392 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 27% | 0.83 | 90 / 328 | 2% | 0.04 | 3 / 178 |
tonsil | 0% | 0 | 0 / 0 | 27% | 1.19 | 12 / 45 |
blood vessel | 25% | 0.91 | 338 / 1335 | 0% | 0 | 0 / 0 |
muscle | 24% | 0.80 | 192 / 803 | 0% | 0 | 0 / 0 |
heart | 16% | 0.43 | 134 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.32 | 4 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006955 | Biological process | immune response |
GO_0016064 | Biological process | immunoglobulin mediated immune response |
GO_0071735 | Cellular component | IgG immunoglobulin complex |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0003823 | Molecular function | antigen binding |
GO_0005515 | Molecular function | protein binding |
Gene name | IGLL1 |
Protein name | Immunoglobulin lambda like polypeptide 1 Immunoglobulin lambda-like polypeptide 1 (CD179 antigen-like family member B) (Ig lambda-5) (Immunoglobulin omega polypeptide) (Immunoglobulin-related protein 14.1) (CD antigen CD179b) |
Synonyms | IGL1 |
Description | FUNCTION: Critical for B-cell development. . |
Accessions | ENST00000330377.3 [P15814-1] ENST00000438703.1 ENST00000249053.3 [P15814-2] C9JEE0 P15814 |